Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents

Overview of attention for article published in Biologics: Targets & Therapy, June 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 284)
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet

patent: 21 patents

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 141 Mendeley

So far, Altmetric has seen 21 patents that reference this research output.

Dove Medical Press

Article Metrics

Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents

About this Attention Score

Mentioned by

Citations

Readers on

Antibodies specifically binding to MASP-3 for the treatment of various diseases and…

Grant US-11883493-B2

United States of America

Antibodies to the C3D fragment of complement component 3

Grant US-RE49339-E1

United States of America

Anti-C3d antibody conjugates and methods of detecting complement activation

Grant US-11191851-B2

United States of America

Reagents and methods for detecting PNH type II white blood cells and their identification…

Grant US-11112402-B2

United States of America

Antibodies specifically binding to MASP-3 for the treatment of various diseases and…

Grant US-11027015-B2

United States of America

Antibodies specifically binding to MASP-3 for the treatment of various diseases and…

Grant US-10639369-B2

United States of America

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states…

Grant US-10239937-B2

United States of America

Methods for treating conditions associated with MASP-2 dependent complement activation

Grant US-10202465-B2

United States of America

Reagents and methods for detecting PNH type II white blood cells and their identification…

Grant US-10126293-B2

United States of America

Methods for treating conditions associated with MASP-2 dependent complement activation

Grant US-10059776-B2

United States of America

Antibodies to the C3d fragment of complement component 3

Grant US-9815890-B2

United States of America

Complement receptor 2 (CR2) targeting groups

Grant US-9650447-B2

United States of America

Methods for treating conditions associated with MASP-2 dependent complement activation

Grant US-9644035-B2

United States of America

Anti-C3d antibody conjugates and methods of detecting complement activation

Grant US-9259488-B2

United States of America

Targeting complement factor H for treatment of diseases

Grant US-9212212-B2

United States of America

Methods of stimulating liver regeneration

Grant US-9066925-B2

United States of America

Methods for treating conditions associated with MASP-2 dependent complement activation

Grant US-8951522-B2

United States of America

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA, HEMOLYTIC ANEMIAS AND DISEASE STATES…

Application EP-2496259-A4

European Patent Office

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states…

Application CN-102958535-A

China

REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION…

Application US-20130045192-A1

United States of America

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA, HEMOLYTIC ANEMIAS AND DISEASE STATES…

Application EP-2496259-A1

European Patent Office